Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
MaSTherCell
MaSTherCell
Activities:
Manufacturing
Pharmaceutical
Cell & Gene Therapy
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Manufacturing
Catalent adds to regenerative therapy portfolio with $315m acquisition
Belgian CDMO MaSTherCell Global is a technology-focused cell and gene therapy CDMO
Manufacturing
MaSTherCell announces new cell and gene therapy facility in Belgium
The new facility will be built to manufacture late-stage and commercially-approved cell and gene therapy products on the Gosselies Biopark site
Estates & Facilities
Biotech manufacturing services agreement in Europe announced
MaSTherCell will manufacture tumour infiltrating lymphocyte for Iovance’s European late-stage clinical trials
Research & Development
CRISPR Therapeutics and MaSTherCell SA develop allogeneic cell therapies
CRISPR Therapeutics and MaSTherCell SA sign an agreement to develop and manufacture allogeneic CAR-T therapies
Manufacturing
Servier appoints MaSTherCell to develop its cell therapy manufacturing platform
MaSTherCell is developing CAR-T cell therapy manufacturing platform, enabling industrial manufacturing of Servier products
Manufacturing
TxCell signs strategic agreement with MaSTherCell to manufacture cell therapy products
Company commits to an ambitious product development schedule with two discovery platforms
Finance
Orgenesis acquires cell therapy manufacturer MaSTherCell
Acquisition to accelerate type 1 diabetes therapeutic into clinical trials and diversify future business model and product offering
Subscribe now